4-cyclopropyl-1-(4-fluorophenyl)-1,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one, 95.0%, 250mg

(E)-(3-(3-Ethoxy-3-oxoprop-1-en-1-yl)phenyl)boronic acid, 95.0%, 1g

Ethyl (E)-3-cyclopentylacrylate, 95%, 5g

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 5mg

5-Bromo-N-ethylpyridin-2-amine, 95.0%, 1g

2-Iodo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

Methyl 5-bromothiazole-4-carboxylate, 97.0%, 10g

3-Cyano-4-isobutoxybenzoic acid, 95+%, 100mg

ethyl 7-(2,6-difluorophenyl)-7-oxoheptanoate, 97.0%, 2g

Boc-O-benzyl-N-methyl-L-threonine cyclohexylamine, 5g

tert-Butyl 4-(dimethylamino)-4-(trifluoromethyl)piperidine-1-carboxylate, 98%, 500mg

Diphenyl Disulfide>99.0%(GC)500g

N-Boc-(Methylamino)acetaldehyde, 94.0%, 5g